期刊名：Cancers

期刊主页：https://www.mdpi.com/journal/cancers

还在为筛选文献而发愁？别急，这份“乳腺癌治疗”方向的文献清单，也许能为你提供灵感！

01

乳腺癌幸存者中的更年期激素替代疗法

Menopausal Hormone Therapy in Breast Cancer Survivors

https://www.mdpi.com/2072-6694/16/19/3267

02

PLK1抑制剂Onvansertib增强PIK3CA突变型HR阳性且对Palbociclib及内分泌治疗耐药的乳腺癌中Alpelisib的疗效：临床前见解

PLK1 Inhibitor Onvansertib Enhances the Efficacy of Alpelisib in PIK3CA-Mutated HR-Positive Breast Cancer Resistant to Palbociclib and Endocrine Therapy: Preclinical Insights

https://www.mdpi.com/2072-6694/16/19/3259

03

范式转变：新辅助治疗在早期乳腺癌中的革新作用

Shifting the Paradigm: The Transformative Role of Neoadjuvant Therapy in Early Breast Cancer

https://www.mdpi.com/2072-6694/16/18/3236

04

引入教育视频以优化乳腺癌患者术后放疗知情同意过程

Introduction of an Educational Video to Enhance the Informed Consent Process in Postoperative Radiation Therapy of Breast Cancer Patients

https://www.mdpi.com/2072-6694/16/20/3552

05

乳腺癌靶向治疗：抗体-药物偶联物―一种化疗-生物药杂交药物的优势与进展

Targeted Therapy in Breast Cancer: Advantages and Advancements of Antibody–Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs

https://www.mdpi.com/2072-6694/16/20/3517

06

新辅助治疗后HER2阳性乳腺癌患者接受辅助T-DM1的耐受性与初步疗效：ATD研究结果

Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study

https://www.mdpi.com/2072-6694/16/23/4104

07

针对接受辅助激素治疗的乳腺癌幸存者的数字康复计划：一项可行性研究

Digital Rehabilitation Program for Breast Cancer Survivors on Adjuvant Hormonal Therapy: A Feasibility Study

https://www.mdpi.com/2072-6694/16/23/4084

08

乳腺癌脑转移系统治疗的当前证据及新药、联合用药与给药途径的未来展望：一项叙述性综述

Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review

https://www.mdpi.com/2072-6694/16/24/4164

09

ChatGPT对第十八届圣加伦国际早期乳腺癌治疗共识会议建议的契合度

ChatGPTs Agreement with the Recommendations from the 18th St. Gallen International Consensus Conference on the Treatment of Early Breast Cancer

https://www.mdpi.com/2072-6694/16/24/4163

10

转移性乳腺癌抗体-药物偶联物治疗的预测因素：一项叙述性综述

Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review

https://www.mdpi.com/2072-6694/16/23/4082

11

Elesclomol (埃莱司库莫) 联合糖酵解抑制剂对乳腺癌腺癌细胞体外细胞毒性的增强作用

The In Vitro Cytotoxic Effect of Elesclomol on Breast Adenocarcinoma Cells Is Enhanced by Concurrent Treatment with Glycolytic Inhibitors

https://www.mdpi.com/2072-6694/16/23/4054

12

XPO1抑制剂在治疗三阴性乳腺癌中的发现、验证及作用机制研究

Discovery, Validation and Mechanistic Study of XPO1 Inhibition in the Treatment of Triple-Negative Breast Cancer

https://www.mdpi.com/2072-6694/16/23/3980

13

为HER2阳性早期乳腺癌患者制定降级治疗策略

De-Escalating Treatment Strategies for Patients with Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Early-Stage Breast Cancer

https://www.mdpi.com/2072-6694/16/20/3478

14

不同运动模式持续六个月对乳腺癌治疗后幸存者应激反应的影响

Impact of Six Months of Three Different Modalities of Exercise on Stress in Post-Treatment Breast Cancer Survivors

https://www.mdpi.com/2072-6694/16/19/3398

15

细胞毒性自噬：一种利用齐墩果酸与熊果酸治疗乳腺癌的新型治疗范式

Cytotoxic Autophagy: A Novel Treatment Paradigm against Breast Cancer Using Oleanolic Acid and Ursolic Acid

https://www.mdpi.com/2072-6694/16/19/3367

Cancers 期刊介绍

主编：Samuel C. Mok, The University of Texas MD Anderson Cancer Center, USA

期刊主题涵盖癌症治疗和免疫疗法、癌症生物标志物、流行病学和预防、肿瘤微环境、癌症病因和筛查、诊断和护理、癌症分子生物学等肿瘤学领域的各个方面。目前，期刊已被SCIE、Scopus、PubMed等重要数据库收录。